Implementation research/real life assessment of existing interventions in women and children’s health

This program targets research entities and organizations focused on improving health outcomes for women and children in specific global regions. Eligibility is primarily for legal entities within EU Member States, associated countries, and certain sub-Saharan African nations, emphasizing collaborative consortiums.

This program supports registration (Phase III) and post-registration clinical studies of health technologies targeting specific infectious diseases affecting pregnant women and young children. The focus is on implementing proven interventions and translating research into healthcare policy and practice within sub-Saharan Africa. Pre-clinical research and early-stage trials are excluded.

This funding is provided as a grant, with a specific maximum amount per project. It operates within the Horizon Europe framework, providing financial support for research and innovation actions.

Applicants must adhere to specific admissibility, eligibility, financial, and operational capacity conditions, including strict consortium composition rules emphasizing participation from sub-Saharan African entities. Projects are subject to exploitation obligations to ensure broad and fair access to results, and the granting authority retains the right to object to certain transfers of ownership.

The application process for this call was a single-stage submission. Evaluation involved specific scoring thresholds across excellence, impact, and implementation quality.

The program is established and governed by comprehensive EU regulations, primarily the Council Regulation establishing Joint Undertakings under Horizon Europe, along with several Horizon Europe Work Programme Annexes. These foundational documents detail everything from eligibility to grant agreements, ensuring legal compliance and operational transparency.